Clinitech Laboratory Ltd - Stock Valuation and Financial Performance

BSE: 544220 | NSE: | Hospital & Healthcare Services | Small Cap

Clinitech Laboratory Share Price

62.06 -6.89 -9.99%
as on 03-Mar'25 16:59

DeciZen - make an informed investing decision on Clinitech Laboratory

M-Cap below 100cr DeciZen not available

Clinitech Laboratory stock performance -

P/E Ratio (SA):
38.16
Market Cap:
14.2 Cr.
52-wk low:
62
52-wk high:
120.8

Is Clinitech Laboratory Ltd an attractive stock to invest in?

1. Is Clinitech Laboratory Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Clinitech Laboratory Ltd is a average quality company.

2. Is Clinitech Laboratory Ltd undervalued or overvalued?

The key valuation ratios of Clinitech Laboratory Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Clinitech Laboratory Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Clinitech Laboratory Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Clinitech Laboratory:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Clinitech Laboratory Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 32.5%32.6%30.4%15.3%-
Value Creation
Index
1.31.31.20.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4.66.46.46.46
Sales YoY Gr.-40.2%-0.5%0.8%-
Adj EPS 2.73.44.12.21.6
YoY Gr.-27.6%19.6%-47.2%-
BVPS (₹) 9.312.315.921.140.9
Adj Net
Profit
0.40.50.60.40
Cash Flow from Ops. 0.411.30.1-
Debt/CF from Ops. 1.40.90.87.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA12%0.8%
Adj EPS NANA-6.9%-47.2%
BVPSNANA31.6%33.1%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
28.931.72912.35.3
Op. Profit
Mgn %
18.216.721.515.6NAN
Net Profit
Mgn %
8.889.75.75.8
Debt to
Equity
0.40.50.40.2-
Working Cap
Days
07471910
Cash Conv.
Cycle
0-10-9120

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 12.04%

Return on Equity has declined versus last 3 years average to 5.30%

Net Profit has been subdued in last 3 years -6.94%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Clinitech Laboratory Ltd.

Standalone Consolidated
TTM EPS (₹) 1.6 -
TTM Sales (₹ Cr.) 6.4 -
BVPS (₹.) 40.9 -
Reserves (₹ Cr.) 7 -
P/BV 1.52 -
PE 38.16 -
From the Market
52 Week Low / High (₹) 62.00 / 120.75
All Time Low / High (₹) 62.00 / 120.75
Market Cap (₹ Cr.) 14.2
Equity (₹ Cr.) 2.3
Face Value (₹) 10
Industry PE 37.9

Quarterly Results

 Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %Mar'25 YoY Gr. Rt. %
Sales (₹ Cr.) 0 N/A0 N/A0 N/A0 N/A
Adj EPS (₹) 0 N/A0 N/A0 N/A0 N/A
Op. Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A
Net Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A

Management X-Ray of Clinitech Laboratory:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:61.58%Institutions:0.32%Non-Institutions:38.11%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep240%10%20%30%40%50%60%70%
Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Clinitech Laboratory

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Clinitech Laboratory

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Narayana Hrudayalay 1,615.4 171 (11.8%) Small Cap 5,018 38.4 15.7 42.1 9.7
Aster DM Healthcare 394.1 -8.6 (-2.1%) Small Cap 3,699 105.6 5.5 3.7 5.6
Dr. Lal Pathlabs 2,347.8 38.1 (1.7%) Small Cap 1,967 55.3 19.5 42.5 9
Indraprastha Medical 342.3 -15.3 (-4.3%) Small Cap 1,245 16.5 10 20.8 5.6
RainbowChildrenS Med 1,245.8 2.6 (0.2%) Small Cap 1,237 23 17.4 54.2 8.8
Krishna Inst.Medi 519.9 -0.6 (-0.1%) Small Cap 1,222 6.4 19.3 80.8 10
Kovai Medical Center 4,979.5 -396.2 (-7.4%) Small Cap 1,220 188.7 14.8 26.4 5.3
Metropolis Health. 1,564.1 -22.7 (-1.4%) Small Cap 1,208 29.7 11 52.7 6.6
HealthcareGlobal 490.6 -13 (-2.6%) Small Cap 1,099 -0.8 3 - 5.8
Jupiter Life Line 1,443.6 5.3 (0.4%) Small Cap 911 28 16.7 51.6 6.9
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24
Sales4.556.386.356.40
Operating Expenses 3.735.324.985.40
Manufacturing Costs0.340.450.310.33
Material Costs1.021.451.171.10
Employee Cost 0.921.381.551.92
Other Costs 1.442.041.962.05
Operating Profit 0.831.071.361
Operating Profit Margin (%) 18.2%16.7%21.5%15.6%
Other Income 0.040.070.020.04
Interest 0.080.060.070.09
Depreciation 0.250.380.450.44
Exceptional Items 0000
Profit Before Tax 0.550.700.860.51
Tax 0.140.190.250.13
Profit After Tax 0.400.510.610.37
PAT Margin (%) 8.8%8.0%9.7%5.8%
Adjusted EPS (₹)2.73.44.12.2
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 1.391.852.383.55
Share Capital 0.671.501.501.68
Reserves 0.720.350.881.87
Minority Interest0000
Debt0.480.810.950.81
Long Term Debt0.480.360.280.23
Short Term Debt00.460.670.58
Trade Payables0.460.520.400.35
Others Liabilities 0.310.402.140.74
Total Liabilities 2.643.585.885.44

Fixed Assets

Gross Block2.453.523.654.47
Accumulated Depreciation1.611.872.322.76
Net Fixed Assets0.841.651.331.71
CWIP 0.080.410.560.94
Investments 0.090.142.020.07
Inventories0.090.160.140.28
Trade Receivables0.560.360.490.60
Cash Equivalents 0.320.100.780.70
Others Assets0.660.760.551.13
Total Assets 2.643.585.885.44

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0.380.961.250.11
PBT 0.550.700.860.51
Adjustment 0.170.310.410.59
Changes in Working Capital -0.180.150.28-0.84
Tax Paid -0.15-0.21-0.30-0.14
Cash Flow From Investing Activity 0.54-1.47-0.65-0.64
Capex -0.19-1.51-0.28-1.21
Net Investments 0.59-0.05-1.881.95
Others 0.140.101.51-1.38
Cash Flow From Financing Activity -0.880.290.090.45
Net Proceeds from Shares 0000.68
Net Proceeds from Borrowing -0.55-0.12-0.08-0.05
Interest Paid -0.08-0.06-0.06-0.07
Dividend Paid 0000
Others -0.250.470.22-0.12
Net Cash Flow 0.04-0.220.68-0.08
PARTICULARSMar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)28.9431.662912.52
ROCE (%)32.4732.6130.3915.31
Asset Turnover Ratio1.722.051.341.13
PAT to CFO Conversion(x)0.951.882.050.3
Working Capital Days
Receivable Days45262531
Inventory Days77912
Payable Days165123144123

Clinitech Laboratory Ltd Stock News

Clinitech Laboratory Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Clinitech Laboratory on 03-Mar-2025 16:59 is ₹62.06.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Mar-2025 16:59 the market cap of Clinitech Laboratory stood at ₹14.16.
The latest P/E ratio of Clinitech Laboratory as of 03-Mar-2025 16:59 is 38.16.
The latest P/B ratio of Clinitech Laboratory as of 03-Mar-2025 16:59 is 1.52.
The 52-week high of Clinitech Laboratory is ₹120.8 and the 52-week low is ₹62.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Clinitech Laboratory is ₹6.40 ( Cr.) .

About Clinitech Laboratory Ltd

The company was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of the company was changed to public limited and the name of the company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24, 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25, 2023 by the Registrar of Companies, Mumbai.

The company is a provider of diagnostic and healthcare tests and services through chain of several diagnostic centers in and around Thane and Navi Mumbai. Its Promoters have many years of experience in diagnostic business. It conducts lakhs of tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and high-end equipment. It conducts various tests at its centres which are classified under various heads as under: Biochemistry tests; Immunology tests; Hematology tests; Molecular Biology tests; Serology tests; Microbiology tests; and Histopathology tests.  

Business area of the company

The company is one of the most trusted diagnostic centers & pathology labs.

Major Events and Milestones

  • 2010: Incorporation of the company.
  • 2012: Established new Lab at Kalyan.
  • 2016: NABL Accreditation at Airoli Centre.
  • 2018: Established new Lab at Thane.
  • 2021: NABL Accreditation for SARS-COV-2 testing.
  • 2021: Signed up agreements for Diagnostic Centre at Kharghar.
  • 2022: Signed up agreements for Diagnostic Centre at Panvel / Badlapur.
  • 2023: Converted Company to Limited.
  • 2023: Established new Lab at Murbad and Panvel. 


Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...